Aromatase Inhibitors in Breast Cancer: A Review of Cost Considerations and Cost Effectiveness

Author： Karnon Jonathan  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.24, Iss.3, 2006-01, pp. : 215-232

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Methodological Issues in Evaluating Cost Effectiveness of Adjuvant Aromatase Inhibitors in Early Breast Cancer: A Need for Improved Modelling to Aid Decision Making

By Annemans Lieven  

PharmacoEconomics, Vol. 26, Iss. 5, 2008-01 ,pp. : 409-423

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Cholinesterase Inhibitors in the Treatment of Alzheimer's Disease: A Review with Methodological Considerations

By Wimo A.  

Drugs & Aging, Vol. 21, Iss. 5, 2004-01 ,pp. : 279-295

Adis International

Access to resources Recommend Favorite

Aromatase inhibitors for breast cancer: pharmacoeconomic considerations

By Higa Gerald M  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 6, 2001-06 ,pp. : 987-995

Informa Healthcare

Access to resources Recommend Favorite

Review of cost-effectiveness analyses in hormonal therapies in advanced breast cancer

By Benedict Ágnes   Brown Ruth E  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 11, 2005-09 ,pp. : 1789-1801

Informa Healthcare

Access to resources Recommend Favorite

Breast Cancer Management: Quality-of-Life and Cost Considerations

By Radice D.   Redaelli A.  

PharmacoEconomics, Vol. 21, Iss. 6, 2003-01 ,pp. : 383-396

Adis International

Access to resources Recommend Favorite